title: Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct.
authors.forename: Mike
authors.initials: M
authors.lastname: Mitka
mesh_terms: D001384:Azetidines / Q000627:therapeutic use*; D017277:Drug Approval; D004338:Drug Combinations; D004345:Drug Industry; D000069499:Ezetimibe, Simvastatin Drug Combination; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016365:Liability, Legal; D016032:Randomized Controlled Trials as Topic; D019821:Simvastatin / Q000627:therapeutic use*; D014481:United States
chemical_list: D001384:Azetidines; D004338:Drug Combinations; D000069499:Ezetimibe, Simvastatin Drug Combination; D000960:Hypolipidemic Agents; D019821:Simvastatin